Swiss pharmaceuticals company Novartis says it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year
Related posts
-
Review: ‘Clue: A Walking Mystery’ sends you scavenging the Loop to solve a puzzle
The ticketed experience is back in Chicago for a second summer. You get in your steps,... -
‘The love of my life’: Arlington Heights couple renew vows to mark 70th anniversary
Surrounded by children and grandchildren, Al and Jane Klein renewed their marital vows Sunday, 70 years... -
Cubs unveil statue depicting Hall of Famer Ryne Sandberg in a familiar defensive crouch
Ryne Sandberg hopes Cubs fans remember him as an alert and active defensive player.